Table 1: Clinical features and antimicrobial susceptibility of P. aeruginosa (Pa) strains.
|
Clinical evaluations |
Pa CMC-097 |
Pa CMC-115 |
||
|
Fever |
Yes (104.7 F) |
Yes (101.1 F) |
||
|
Cough |
Yes |
Yes |
||
|
Sputum Production |
Yes |
Yes |
||
|
Δ quantity/color |
No |
Yes |
||
|
Increase O2 required |
No |
Yes |
||
|
Infiltrate on CXR |
No |
No |
||
|
Elevated WBC |
Yes (11.2) |
Yes (13.8) |
||
|
Chronic Vent |
Yes |
No |
||
|
Recent Pseudomonas Pneumonia |
Yes (2 weeks PTA) |
No |
||
|
MDR Isolate |
Yes |
No |
||
|
Alternative DX |
Yes (PICC-line infection) |
Yes (E. coli, UTI) |
||
|
Assessment |
Late Colonization or Chronic |
Early Colonization Vs. Early Infection |
||
|
Antimicrobial testing* |
Susceptibility results and interpretation |
|||
|
Amikacin |
16 |
Sensitive |
< = 2 |
Sensitive |
|
Ciprofloxacin |
> = 4 |
Resistant |
2 |
Sensitive |
|
Gentamicin |
> = 16 |
Resistant |
< = 1 |
Sensitive |
|
Meropenem |
> = 16 |
Resistant |
< = 0.25 |
Sensitive |
|
Tobramycin |
> = 16 |
Resistant |
< = 0.25 |
Sensitive |
|
Piperacilin/Tazobactam |
> = 128 |
Resistant |
< = 1 |
Sensitive |
*MICs determined by using ASTGN45 card.